1. Home
  2. AXTI vs VERU Comparison

AXTI vs VERU Comparison

Compare AXTI & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • VERU
  • Stock Information
  • Founded
  • AXTI 1986
  • VERU 1971
  • Country
  • AXTI United States
  • VERU United States
  • Employees
  • AXTI N/A
  • VERU N/A
  • Industry
  • AXTI Semiconductors
  • VERU Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXTI Technology
  • VERU Health Care
  • Exchange
  • AXTI Nasdaq
  • VERU Nasdaq
  • Market Cap
  • AXTI 84.8M
  • VERU 94.5M
  • IPO Year
  • AXTI 1998
  • VERU 1990
  • Fundamental
  • Price
  • AXTI $2.56
  • VERU $0.56
  • Analyst Decision
  • AXTI Strong Buy
  • VERU Strong Buy
  • Analyst Count
  • AXTI 4
  • VERU 2
  • Target Price
  • AXTI $4.69
  • VERU $4.00
  • AVG Volume (30 Days)
  • AXTI 728.8K
  • VERU 2.7M
  • Earning Date
  • AXTI 07-31-2025
  • VERU 08-07-2025
  • Dividend Yield
  • AXTI N/A
  • VERU N/A
  • EPS Growth
  • AXTI N/A
  • VERU N/A
  • EPS
  • AXTI N/A
  • VERU N/A
  • Revenue
  • AXTI $96,029,000.00
  • VERU $16,886,419.00
  • Revenue This Year
  • AXTI N/A
  • VERU N/A
  • Revenue Next Year
  • AXTI $27.18
  • VERU N/A
  • P/E Ratio
  • AXTI N/A
  • VERU N/A
  • Revenue Growth
  • AXTI 21.44
  • VERU 134.43
  • 52 Week Low
  • AXTI $1.13
  • VERU $0.45
  • 52 Week High
  • AXTI $4.03
  • VERU $1.42
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 69.02
  • VERU 48.60
  • Support Level
  • AXTI $1.97
  • VERU $0.56
  • Resistance Level
  • AXTI $2.49
  • VERU $0.73
  • Average True Range (ATR)
  • AXTI 0.15
  • VERU 0.04
  • MACD
  • AXTI 0.02
  • VERU -0.01
  • Stochastic Oscillator
  • AXTI 89.13
  • VERU 16.76

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Share on Social Networks: